Skip to main content
Roger Lyons, MD, Hematology, San Antonio, TX, CHRISTUS Santa Rosa Health System

RogerMLyonsMDF.A.C.P.

Hematology San Antonio, TX

President Cancer Care Centers of South Texas

Dr. Lyons is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Lyons' full profile

Already have an account?

Education & Training

  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumFellowship, Hematology and Medical Oncology, 1972 - 1975
  • Washington University/B-JH/SLCH Consortium
    Washington University/B-JH/SLCH ConsortiumResidency, Internal Medicine, 1971 - 1972
  • University of Manitoba
    University of ManitobaClass of 1967

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1975 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Awards, Honors, & Recognition

  • America's Top Doctors Castle Connolly, 2004-2014
  • Top Doctors:SE Texas Castle Connolly, 2013
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Abstracts/Posters

  • Real-World (RW) Treatment Patterns and Patient-Related Factors Including Quality of Life (QoL), Medication Adherence, and Actigraphy in Community Patients (pts) with N...
    Roger M. Lyons, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
  • Long-Term Proteasome Inhibitor (PI) Therapy in Community Patients (Pts) with Newly Diagnosed Multiple Myeloma (NDMM) Transitioning from Bortezomib (Btz)-Based to Ixazo...
    Roger M. Lyons, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Disease and Clinical Characteristics of Patients with Myelofibrosis Enrolled in the MOST Study
    Roger M. Lyons, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Hospital Affiliations